PALATIN TECHNOLOGIES, INC. Segment Reporting Other Item Amount
PALATIN TECHNOLOGIES, INC. (PTN) reported Segment Reporting Other Item Amount of -$148.01 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for the quarter ending 2026-03-31 was -$148.01K.
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for the quarter ending 2025-12-31 was -$64.69K.
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for the quarter ending 2025-09-30 was -$16.48K, a 127.95% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for the quarter ending 2025-06-30 was -$40.96K.
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for fiscal 2025 was -$152.59K.
- PALATIN TECHNOLOGIES, INC. segment reporting other item amount for fiscal 2024 was -$419.48K.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$148.01K 10-Q · filed 2026-05-13 | -$212.69K derived: sum of 2 quarters · filed 2026-05-13 | -$229.18K 10-Q · filed 2026-05-13 | -$270.13K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | -$64.69K 10-Q · filed 2026-02-17 | -$81.17K 10-Q · filed 2026-02-17 | -$122.13K derived: sum of 3 quarters · filed 2026-02-17 | -$123.88K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-09-30 | -$16.48K 10-Q · filed 2025-11-14 | -$57.44K derived: sum of 2 quarters · filed 2025-11-14 | -$59.20K derived: sum of 3 quarters · filed 2026-05-13 | -$228.04K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | -$40.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$42.71K derived: sum of 2 quarters · filed 2026-05-13 | -$211.56K derived: sum of 3 quarters · filed 2026-05-13 | -$152.59K 10-K · filed 2025-09-23 |
| 2025-03-31 | -$1.76K 10-Q · filed 2026-05-13 | -$170.60K derived: sum of 2 quarters · filed 2026-05-13 | -$111.63K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | -$168.84K 10-Q · filed 2026-02-17 | -$109.88K 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | $58.96K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$419.48K 10-K · filed 2025-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |